# Hims & Hers Health Inc. (HIMS) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Healthcare / Health Care Providers. Price $25.70, market value $6.0 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Hims & Hers Health Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.3×**. Each dollar of revenue is priced at 2.3×.
- **Price / book: 18.5×**. The shares trade at 18.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: 1.0%** (5-yr avg 1.0%). Free cash flow equals 1.0% of the market value, in line with its five-year average of 1.0%.

## Profitability
- **Gross margin: 68.4%**. Hims & Hers Health Inc. keeps 68.4% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -6.0%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: 5.5%**. 5.5% of each dollar of sales reaches the bottom line.
- **Return on equity: 23.7%**. 23.7% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on assets: -6.6%**. Each dollar of assets produces -6.6% of profit.

## Growth
- **Revenue growth (1 yr): 59.0%** (3-yr 64.5%/yr, 5-yr 73.6%/yr). Revenue grew 59.0% over the last year, against 73.6% a year compounded over five years.
- **EPS growth (1 yr): -3.8%**. Earnings per share fell 3.8%, slower than revenue, so margins compressed.

## Financial health
- **Current ratio: 1.90** (quick 1.90). Current assets cover the next year's liabilities 1.90 times.
- **Altman Z-score: 4.03**. A Z-score of 4.03 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Hims & Hers Health Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (13 analysts). 13 analysts cover Hims & Hers Health Inc.; the consensus is hold, with an average price target of $31.15 (+21% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -44.5%** (YTD -22.3%, 3-mo -18.1%). The shares are down 44.5% over twelve months including dividends.
- **From 52-week high: -46.8%** (87.0% above the low). Trading 47% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 37**. An RSI of 37 is neutral.
- **Beta (1 yr): 2.78** (volatility 89%). Beta of 2.78 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=HIMS · Page: https://foliofundamentals.com/stocks/hims

Not investment advice.